Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 15, 2022, 6:44 p.m.

/zigman2/quotes/207821052/composite

$

68.42

Change

0.00 0.00%

Volume

Volume 9,733

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Today's close

$ 67.74

$ 68.42

Change

+0.68 +1.00%

Day low

Day high

$65.72

$69.73

Open

52 week low

52 week high

$37.08

$180.59

Open

Insider Actions for Intellia Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/14/2022 Fred Ehrenkranz Cohen
Director
5,197   Award at $0 per share. 0
06/14/2022 Caroline D. Dorsa
Director
5,197   Award at $0 per share. 0
06/14/2022 Georgia Keresty
Director
5,197   Award at $0 per share. 0
06/14/2022 Muna Bhanji
Director
2,014   Award at $0 per share. 0
06/14/2022 John Francis Crowley
Director
5,197   Award at $0 per share. 0
06/14/2022 Jean-Francois B. Formela
Director
5,197   Award at $0 per share. 0
06/14/2022 Frank A. G. M. Verwiel
Director
5,197   Award at $0 per share. 0
06/14/2022 Jesse L. Goodman
Director
5,197   Award at $0 per share. 0
04/28/2022 Muna Bhanji
Director
7,954   Award at $0 per share. 0
03/01/2022 John M. Leonard
President and CEO; Director
40,990   Award at $0 per share. 0
03/01/2022 David Lebwohl
EVP, Chief Medical Officer
13,816   Award at $0 per share. 0
03/01/2022 Eliana Clark
EVP, Chief Technical Officer
10,527   Award at $0 per share. 0
03/01/2022 Glenn Goddard
EVP, Chief Financial Officer
12,720   Award at $0 per share. 0
01/03/2022 Derek Hicks
EVP, Chief Business Officer
19,118   Award at $0 per share. 0
01/01/2022 John M. Leonard
President and CEO; Director
2,493   Disposition at $112.26 per share. 279,864
01/01/2022 David Lebwohl
EVP, Chief Medical Officer
1,051   Disposition at $112.24 per share. 117,964
01/01/2022 Glenn Goddard
EVP, Chief Financial Officer
1,013   Disposition at $112.24 per share. 113,699
01/01/2022 John M. Leonard
President and CEO; Director
7,848   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2022 David Lebwohl
EVP, Chief Medical Officer
3,187   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2022 Glenn Goddard
EVP, Chief Financial Officer
3,062   Derivative/Non-derivative trans. at $0 per share. 0
11/05/2021 David Lebwohl
EVP, Chief Medical Officer
200   Disposition at $135.34 per share. 27,068
11/05/2021 David Lebwohl
EVP, Chief Medical Officer
548   Disposition at $134.07 per share. 73,470
11/05/2021 David Lebwohl
EVP, Chief Medical Officer
452   Disposition at $132.62 per share. 59,944
11/05/2021 David Lebwohl
EVP, Chief Medical Officer
1,200   Disposition at $131.71 per share. 158,052
11/05/2021 David Lebwohl
EVP, Chief Medical Officer
2,400   Derivative/Non-derivative trans. at $12.62 per share. 30,288
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
250   Disposition at $130.47 per share. 32,617
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
525   Disposition at $129.83 per share. 68,160
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
225   Disposition at $129.01 per share. 29,027
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
849   Disposition at $127.81 per share. 108,510
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
551   Disposition at $126.92 per share. 69,932
10/14/2021 David Lebwohl
EVP, Chief Medical Officer
2,400   Derivative/Non-derivative trans. at $12.62 per share. 30,288
10/11/2021 John Francis Crowley
Director
2,500   Disposition at $119.55 per share. 298,875
10/11/2021 John Francis Crowley
Director
2,500   Derivative/Non-derivative trans. at $18.83 per share. 47,075
10/05/2021 John Francis Crowley
Director
200   Disposition at $132.84 per share. 26,568
10/05/2021 John Francis Crowley
Director
1,846   Disposition at $131.74 per share. 243,192
10/05/2021 John Francis Crowley
Director
3,759   Disposition at $130.92 per share. 492,128
10/05/2021 John Francis Crowley
Director
2,915   Disposition at $129.88 per share. 378,600
10/05/2021 John Francis Crowley
Director
1,280   Disposition at $128.83 per share. 164,902
10/05/2021 John Francis Crowley
Director
10,000   Derivative/Non-derivative trans. at $18.83 per share. 188,300
09/24/2021 David Lebwohl
EVP, Chief Medical Officer
7,923   Derivative/Non-derivative trans. at $12.62 per share. 99,988

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
8 Purchases
0 Sales
38,393
0
Last 6 months
13 Purchases
0 Sales
124,400
0
Last 12 months
37 Purchases
60 Sales
489,313
328,332

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.